The Medical Letter on Drugs and Therapeutics
July 17, 2006
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Inhaled Insulin (Exubera)
July 17, 2006 (Issue: 1239)An inhaled, dry-powder formulation of rapid-acting human insulin (Exubera - Pfizer) has been approved by the FDA for treatment of adults with type 1 or type 2 diabetes.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.